A recent study found that structured cessation programs improve quit rates among lung cancer screening participants. How can physicians leverage this?

After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

Long-term data demonstrate that robust reductions and normalization in key biomarkers from baseline were maintained over time with continued ...

Many young people in the UK don’t understand what being asexual means, and hold both ignorance and intolerance towards this community, a new research study suggests.

Denali Therapeutics (DNLI) announced the primary analysis of the Phase 1/2 study in 47 participants with Hunter syndrome in the 24-week ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

It's common for young people leaving jails and prisons to end up back behind bars, often after lapses related to untreated ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Staff, public officials and MSU Mankato students gathered to celebrate the opening of the new Rural Behavioral Health Clinic ...

Last Patient / Last Visit Completed Topline Data Readout Expected Later This Quarter CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc.